Effects of hormonal contraception on vaginal flora

被引:32
作者
De Seta, Francesco [1 ]
Restaino, Stefano
De Santo, Davide
Stabile, Guglielmo
Banco, Rubina
Busetti, Marina
Barbati, Giulia [2 ]
Guaschino, Secondo
机构
[1] Univ Trieste, IRCCS Burlo Garofalo, Inst Maternal & Child Hlth, Dept Obstet & Gynecol, I-34137 Trieste, Italy
[2] Univ Padua, Dept Environm Med & Publ Hlth, I-35122 Padua, Italy
关键词
Vaginal ring; Lactobacilli; Oral contraceptive; Vaginal flora; Leukocytes; BACTERIAL VAGINOSIS; ORAL-CONTRACEPTIVES; HYDROGEN-PEROXIDE; RING; FORMULATIONS; WOMEN;
D O I
10.1016/j.contraception.2012.02.012
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The sector of the market that deals with contraception offers a long list of different contraceptive methods. Within the estroprogestinic choice, the routes of administration are oral, transdermic and vaginal one. Even though efficacy is comparable with these methods, secondary and adverse effects are directly involved in the acceptability of the method. Study Design: This was a prospective comparative study. During I year, we enrolled 60 asymptomatic women who voluntarily requested combined oral contraception (COC) or combined contraceptive vaginal ring (CCVR group). After a baseline study of vaginal milieu prior to starting hormonal contraception, we performed a follow-up. For each woman, we examined vaginal pH; quantification of leukocytes, lactobacilli, Candida and cocci on saline microscopy fluid; Gram stain with Nugent score and the presence of vaginal infection [culture for Trichomonas vaginalis, albicans and nonalbicans Candida, Group B Streptococcus (GBS)]. Results: At the end of follow-up, there was a little change of vaginal milieu in both groups. We noted an increase of lactobacilli in the CCVR users and an increase of GBS in COC users. Conclusion: CCVR compared to COC users showed an increase of the number of lactobacilli in vaginal flora. It means that an increase of leukorrhea in that group could be protective in terms of prevention of vaginal imbalance/infection. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:526 / 529
页数:4
相关论文
共 15 条
[1]   Update on contraception: Benefits and risks of the new formulations [J].
Batur, P ;
Elder, J ;
Mayer, M .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2003, 70 (08) :681-+
[2]   Contraceptive vaginal rings: a review [J].
Brache, Vivian ;
Faundes, Anibal .
CONTRACEPTION, 2010, 82 (05) :418-427
[3]   PREVALENCE OF HYDROGEN PEROXIDE-PRODUCING LACTOBACILLUS SPECIES IN NORMAL WOMEN AND WOMEN WITH BACTERIAL VAGINOSIS [J].
ESCHENBACH, DA ;
DAVICK, PR ;
WILLIAMS, BL ;
KLEBANOFF, SJ ;
YOUNGSMITH, K ;
CRITCHLOW, CM ;
HOLMES, KK .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (02) :251-256
[4]   Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium [J].
Eschenbach, DA ;
Patton, DL ;
Meier, A ;
Thwin, SS ;
Aura, J ;
Stapleton, A ;
Hooton, TM .
CONTRACEPTION, 2000, 62 (03) :107-112
[5]   Vaginal ring contraception [J].
Kerns, Jennifer ;
Darney, Philip .
CONTRACEPTION, 2011, 83 (02) :107-115
[6]   Skin patch and vaginal ring versus combined oral contraceptives for contraception [J].
Lopez, Laureen M. ;
Grimes, David A. ;
Gallo, Maria F. ;
Schulz, Kenneth F. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (03)
[7]   Clinical experience with NuvaRing® in daily practice in Switzerland:: Cycle control and acceptability among women of all reproductive ages [J].
Merki-Feld, Gabriele S. ;
Hund, Martin .
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2007, 12 (03) :240-247
[8]   RELIABILITY OF DIAGNOSING BACTERIAL VAGINOSIS IS IMPROVED BY A STANDARDIZED METHOD OF GRAM STAIN INTERPRETATION [J].
NUGENT, RP ;
KROHN, MA ;
HILLIER, SL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) :297-301
[9]   Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial [J].
Oddsson, K ;
Leifels-Fischer, B ;
de Melo, NR ;
Wiel-Masson, D ;
Benedetto, C ;
Verhoeven, CHJ ;
Dieben, TOM .
CONTRACEPTION, 2005, 71 (03) :176-182
[10]  
Roumen Frans Jme, 2008, Ther Clin Risk Manag, V4, P441